Furthermore, increased risk of Alzheimer’s disease and Parkinson’s disease has been associated with the incidence of single-nucleotide polymorphisms in CLOCK and BMAL1, and in BMAL1 and PER1, respectively (Logan and McClung, 2019). Here, BMAL1 is linked to Alzheimer disease.